Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-22

Clinical Trial Update: A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712) [Phase 4]

View source ↗

Summary

Phase 4 study comparing the onset of action of loratadine and fexofenadine in participants with seasonal allergic rhinitis; the trial is completed and results a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexofenadine (fexofenadine)
  • Loratadine (Loratadine)

Snippet

Sponsor: Bayer | Conditions: Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2013-03-22